SHC3
Basic information
Region (hg38): 9:89005771-89178818
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SHC3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 47 | 49 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 47 | 4 | 0 |
Variants in SHC3
This is a list of pathogenic ClinVar variants found in the SHC3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-89013473-G-T | not specified | Uncertain significance (May 13, 2024) | ||
9-89013487-C-T | not specified | Uncertain significance (Dec 13, 2023) | ||
9-89038042-A-C | not specified | Uncertain significance (Jun 05, 2024) | ||
9-89038066-G-A | not specified | Uncertain significance (Jul 12, 2022) | ||
9-89038088-C-T | not specified | Uncertain significance (Nov 14, 2024) | ||
9-89038097-C-T | not specified | Uncertain significance (Mar 18, 2024) | ||
9-89038117-C-T | not specified | Uncertain significance (May 11, 2022) | ||
9-89038160-C-T | Likely benign (Jun 26, 2018) | |||
9-89038175-C-G | not specified | Uncertain significance (Mar 20, 2024) | ||
9-89038221-C-A | not specified | Uncertain significance (Dec 30, 2023) | ||
9-89038274-C-A | not specified | Uncertain significance (Nov 15, 2024) | ||
9-89042041-C-T | not specified | Uncertain significance (May 09, 2023) | ||
9-89042057-C-G | not specified | Uncertain significance (Jan 04, 2022) | ||
9-89042072-C-A | Likely benign (Mar 01, 2024) | |||
9-89042113-C-T | not specified | Uncertain significance (Dec 16, 2021) | ||
9-89042122-G-A | not specified | Uncertain significance (Jul 02, 2024) | ||
9-89046906-G-T | not specified | Uncertain significance (Aug 28, 2024) | ||
9-89046956-C-T | not specified | Uncertain significance (Nov 02, 2023) | ||
9-89046966-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
9-89046968-G-A | not specified | Uncertain significance (Aug 11, 2022) | ||
9-89046992-A-T | not specified | Uncertain significance (Nov 15, 2023) | ||
9-89052088-C-T | not specified | Uncertain significance (Jun 28, 2022) | ||
9-89052127-T-C | not specified | Uncertain significance (Sep 12, 2024) | ||
9-89075113-T-C | not specified | Uncertain significance (May 23, 2024) | ||
9-89075149-G-A | not specified | Uncertain significance (Apr 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SHC3 | protein_coding | protein_coding | ENST00000375835 | 12 | 165623 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0465 | 0.953 | 125739 | 0 | 9 | 125748 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.40 | 231 | 299 | 0.773 | 0.0000163 | 3839 |
Missense in Polyphen | 67 | 115.88 | 0.57819 | 1451 | ||
Synonymous | 0.122 | 121 | 123 | 0.986 | 0.00000716 | 1214 |
Loss of Function | 3.26 | 7 | 24.3 | 0.288 | 0.00000118 | 304 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000534 | 0.0000527 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Signaling adapter that couples activated growth factor receptors to signaling pathway in neurons. Involved in the signal transduction pathways of neurotrophin-activated Trk receptors in cortical neurons.;
- Pathway
- Chronic myeloid leukemia - Homo sapiens (human);Gastric cancer - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Relaxin signaling pathway - Homo sapiens (human);Neurotrophin signaling pathway - Homo sapiens (human);Breast cancer - Homo sapiens (human);ErbB signaling pathway - Homo sapiens (human);Chemokine signaling pathway - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Glioma - Homo sapiens (human);Estrogen signaling pathway - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);Natural killer cell mediated cytotoxicity - Homo sapiens (human);Phospholipase D signaling pathway - Homo sapiens (human);Bacterial invasion of epithelial cells - Homo sapiens (human);Prolactin signaling pathway - Homo sapiens (human);Alcoholism - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);EGFR Inhibitor Pathway, Pharmacodynamics;EGF-Core;Integrin-mediated Cell Adhesion;Brain-Derived Neurotrophic Factor (BDNF) signaling pathway;Focal Adhesion;Angiopoietin Like Protein 8 Regulatory Pathway;Chemokine signaling pathway;Ras Signaling;Insulin Signaling;Developmental Biology;Signal Transduction;HGF;IGF signaling;insulin Mam;IL-5 signaling;Signalling to RAS;Signalling to ERKs;Signaling by NTRK1 (TRKA);Integrin;Signaling by NTRKs;BDNF;RAF/MAP kinase cascade;MAPK1/MAPK3 signaling;MAPK family signaling cascades;PDGF;NGF;RET signaling;Axon guidance;Signaling by Receptor Tyrosine Kinases;EGF;Neurotrophic factor-mediated Trk receptor signaling;insulin
(Consensus)
Recessive Scores
- pRec
- 0.153
Intolerance Scores
- loftool
- 0.249
- rvis_EVS
- 0.09
- rvis_percentile_EVS
- 60.47
Haploinsufficiency Scores
- pHI
- 0.464
- hipred
- Y
- hipred_score
- 0.704
- ghis
- 0.538
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.996
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Shc3
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- MAPK cascade;transmembrane receptor protein tyrosine kinase signaling pathway;epidermal growth factor receptor signaling pathway;Ras protein signal transduction;axon guidance;central nervous system development;learning or memory;synaptic transmission, glutamatergic
- Cellular component
- cellular_component;cytosol;plasma membrane
- Molecular function
- phosphotyrosine residue binding;Ras guanyl-nucleotide exchange factor activity;protein binding;receptor tyrosine kinase binding